Indivior PLC Ordinary Shares
INDV
$33.62-1.58%
End of day · as of Oct 16, 2026, 5:46 AM ET
Mkt cap
$4.48B
EV/Sales
3.72
P/E ratio
12.1
FY2025 Revenue
$1.24B
EPS (TTM)
$2.79
Gross Margin (FY2025)
80.23%
Profit Margin (FY2025)
16.95%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B and trailing P/E 12.1.
Use this INDV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INDV income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Indivior PLC Ordinary Shares (INDV) revenue for Dec 31, 2025 was $1.24B. Net income was $210.0M. Statements: https://lician.com/financials/indv
Indivior PLC Ordinary Shares (INDV) trailing P/E is 12.1 on the latest cached fundamentals snapshot.
Indivior PLC Ordinary Shares (INDV) market capitalization is $4.48B on the latest cached snapshot.
Indivior PLC Ordinary Shares (INDV) cached previous close $34.16; day range $33.55 – $34.57; volume 1,411,846. Session quote: https://lician.com/quote/indv
Indivior PLC Ordinary Shares (INDV) latest cached earnings event is "INDV earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INDV filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/indv